Phase 3 Trial of Cabozantinib to Treat Advanced Neuroendocrine Tumors
- Jennifer A Chan
- , Susan Geyer
- , Tyler Zemla
- , Michael V Knopp
- , Spencer Behr
- , Sydney Pulsipher
- , Fang-Shu Ou
- , Amylou C Dueck
- , Jared Acoba
- , Ardaman Shergill
- , Edward M Wolin
- , Thorvardur R Halfdanarson
- , Bhavana Konda
- , Nikolaos A Trikalinos
- , Bernard Tawfik
- , Nitya Raj
- , Shagufta Shaheen
- , Namrata Vijayvergia
- , Arvind Dasari
- , Jonathan R Strosberg
- Dana-Farber Cancer Institute
- Alliance Statistics and Data Management Center
- University of Cincinnati
- University of California at San Francisco
- University of Hawaii Cancer Center
- Alliance Protocol Operations Office, University of Chicago, Chicago
- Mount Sinai Medical Center, New York, NY
- Mayo Clinic Comprehensive Cancer, Rochester MN
- Ohio State University Comprehensive Cancer Center
- Siteman Cancer Center at Barnes-Jewish Hospital and Washington University School of Medicine
- University of New Mexico Comprehensive Cancer Center, Albuquerque NM
- Memorial Sloan-Kettering Cancer Center
- University of Chicago
- University of Texas MD Anderson Cancer Center
- Moffitt Cancer Center
- National Cancer Institute
- Boston University
Research output: Contribution to journal › Article › peer-review
152
Scopus
citations